Skip to main content
Fig. 6 | Journal of Experimental & Clinical Cancer Research

Fig. 6

From: An ABCG2 non-substrate anticancer agent FL118 targets drug-resistant cancer stem-like cells and overcomes treatment resistance of human pancreatic cancer

Fig. 6

In vivo imaging to monitor pancreatic tumor growth and metastasis using an orthotopic LucPANC1 model: Several days after orthotopic implantation of LucPANA1 cells, mice were treated with and without FL118 and cisplatin as show via qw × 4 schedules. a, Bioluminescent images of whole mouse bodies treated with and without FL118 and cisplatin overtime (shown on days 7, 60, 70 and 90). b, Tumor growth curve of bioluminescent image (BLI) was shown as total flux overtime. d, day/days

Back to article page